The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Amgen Inc

Nasdaq: AMGN
Last

(U.S.) $174.01

Today's change+1.40 +0.81%
Updated February 23 4:00 PM EST. Delayed by at least 15 minutes.
 

Amgen Inc

Nasdaq: AMGN
Last

(U.S.) $174.01

Today's change+1.40 +0.81%
Updated February 23 4:00 PM EST. Delayed by at least 15 minutes.

Amgen Inc up (U.S.)$1.40

Amgen Inc closed up Thursday by (U.S.)$1.40 or 0.81% to (U.S.)$174.01. Over the last five days, shares have gained 1.10% and are currently 1.61% off of the 52-week high. Shares have underperformed the S&P 500 by 4.87% during the last year.

Key company metrics

  • Open(U.S.) $172.75
  • Previous close(U.S.) $172.61
  • High(U.S.) $174.01
  • Low(U.S.) $171.89
  • Bid / Ask(U.S.) $173.51 / (U.S.) $174.00
  • YTD % change+19.01%
  • Volume2,191,189
  • Average volume (10-day)3,482,095
  • Average volume (1-month)3,611,888
  • Average volume (3-month)3,994,980
  • 52-week range(U.S.) $133.64 to (U.S.) $176.85
  • Beta1.22
  • Trailing P/E16.96×
  • P/E 1 year forward13.99×
  • Forward PEG2.06×
  • Indicated annual dividend(U.S.) $4.60
  • Dividend yield2.64%
  • Trailing EPS(U.S.) $10.26
Updated February 23 4:00 PM EST. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2016Q3/2016Q2/2016Q1/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedDec 31, 201612/31/2016Sep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016
Revenue5,9655,8115,6885,527
Total other revenue--------
Total revenue5,9655,8115,6885,527
Gross profit4,8984,7844,6384,509
Total cost of revenue1,0671,0271,0501,018
Total operating expense3,4803,2843,3083,125
Selling / general / administrative1,3231,2441,2921,203
Research & development1,078990900872
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)-607827
Other operating expenses, total1823-125
Operating income2,4852,5272,3802,402
Interest income (expense), net non-operating-328-325-313-294
Gain (loss) on sale of assets--------
Other--------
Income before tax2,2832,4182,2042,258
Income after tax1,9352,0171,8701,900
Income tax, total348401334358
Net income1,9352,0171,8701,900
Total adjustments to net income--------
Net income before extra. items1,9352,0171,8701,900
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1,9352,0171,8701,900
Inc. avail. to common incl. extra. items1,9352,0171,8701,900
Diluted net income1,9352,0171,8701,900
Dilution adjustment--------
Diluted weighted average shares742753756760
Diluted EPS excluding extraordinary itemsvalue per share2.612.682.472.50
Dividends per sharevalue per share1.001.001.001.00
Diluted normalized EPSvalue per share2.602.682.562.53